Recent advances in the management and understanding of macular degeneration

Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadorani, Sepehr, Singer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399962/
https://www.ncbi.nlm.nih.gov/pubmed/28491291
http://dx.doi.org/10.12688/f1000research.10998.1
Descripción
Sumario:Current management of age-related macular degeneration (AMD) is directed at intravitreal injection of vascular endothelial growth factor (VEGF) inhibitors for the treatment of wet AMD and supplementation with oral antioxidants for the treatment of dry AMD. In this article, we will review recent clinical trials for the treatment of dry and wet AMD.

Ejemplares similares